C5a anaphylatoxin as a product of complement activation up-regulates the complement inhibitory factor H in rat Kupffer cells

被引:7
作者
Schlaf, G [1 ]
Nitzki, F
Heine, I
Hardeland, R
Schieferdecker, HL
Götze, O
机构
[1] Univ Gottingen, Dept Immunol, D-3400 Gottingen, Germany
[2] Univ Gottingen, Inst Zool Anthropol & Dev Biol, D-3400 Gottingen, Germany
[3] Univ Gottingen, Inst Biochem & Mol Cell Biol, D-3400 Gottingen, Germany
关键词
complement factor H; C5a anaphylatoxin; rat Kupffer cells;
D O I
10.1002/eji.200324806
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The 155-kDa complement regulator factor H (FH) is the predominant soluble regulatory protein of the complement system. It acts as a cofactor for the factor I-mediated conversion of the component C3b to iC3b, competes with factor B for a binding site on C3b and C3(H2O) and promotes the dissociation of the C3bBb complex. The primary site of synthesis is the liver, i.e. FH-specific mRNA and protein were identified in both hepatocytes (HC) and Kupffer cells (KC). Previous studies in rat primary HC and KC had shown that the proinflammatory cytokine IFN-gamma influences the balance between activation and inhibition of the complement system through up-regulation of the inhibitory FH. In this study we show that C5a, as a product of complement activation, stimulates the expression of FH-specific mRNA and protein in KC and thus induces a negative feedback. Quantitative-competitive RT-PCR showed an approximate threefold C5a-induced up-regulation of FH. ELISA analyses revealed a corresponding increase in FH protein in the supernatants of KC. The up-regulation of FH was completely inhibited by the C5a-blocking monoclonal antibody 6-917. Furthermore, an involvement of LPS and IFN-gamma was excluded, which strongly indicates a direct effect of C5a on the expression of FH in KC.
引用
收藏
页码:3257 / 3266
页数:10
相关论文
共 37 条
[1]  
BROOIMANS RA, 1989, J IMMUNOL, V142, P2024
[2]  
BROUWER A, 1984, CENTRIFUGATION PRACT, P193
[3]  
DAHA MR, 1982, J IMMUNOL, V128, P1839
[4]   EXPRESSION OF COMPLEMENT ALTERNATIVE PATHWAY PROTEINS BY ENDOTHELIAL-CELLS - DIFFERENTIAL REGULATION BY INTERLEUKIN-1 AND GLUCOCORTICOIDS [J].
DAUCHEL, H ;
JULEN, N ;
LEMERCIER, C ;
DAVEAU, M ;
OZANNE, D ;
FONTAINE, M ;
RIPOCHE, J .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1990, 20 (08) :1669-1675
[5]   Rat complement factor H:: Molecular cloning, sequencing and quantification with a newly established ELISA [J].
Demberg, T ;
Pollok-Kopp, B ;
Gerke, D ;
Götze, O ;
Schlaf, G .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2002, 56 (02) :149-160
[7]  
DISCIPIO RG, 1992, J IMMUNOL, V149, P2592
[8]   FHL-1/reconectin and factor H: two human complement regulators which are encoded by the same gene are differently expressed and regulated [J].
Friese, MA ;
Hellwage, J ;
Jokiranta, TS ;
Meri, S ;
Peter, HH ;
Eibel, H ;
Zipfel, PF .
MOLECULAR IMMUNOLOGY, 1999, 36 (13-14) :809-818
[9]  
HILL J, 1992, J IMMUNOL, V149, P1723
[10]   THE REGULATORS OF COMPLEMENT ACTIVATION (RCA) GENE-CLUSTER [J].
HOURCADE, D ;
HOLERS, VM ;
ATKINSON, JP .
ADVANCES IN IMMUNOLOGY, 1989, 45 :381-416